Differential expression of TRPM2 between NK cell subtypes may provide evidence for their role in the pathomechanism involving NK cell cytotoxicity activity in ME/CFS. This evidence concerns the gene TRPM2 and myalgic encephalomeyelitis/chronic fatigue syndrome.